By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Singapore genomics service firm AITBiotech announced it has licensed molecular assays developed by research institutes under Singapore's Agency for Science Technology and Research (A*STAR).

The assays were licensed from Exploit Technologies, the marketing and commercialization arm of A*STAR.
The agreement covers dengue/chikungunya multiplex detection kits and a Mycobacterium tuberculosis detection kit. The kits are used with PCR systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.